Last updated 2026-07-20
Portfolio
0
in our dataset
Rounds participated
0
Rounds led
0
Rounds' value
—
total disclosed, rounds participated
Stages
—
About
Auriga Partners is a venture capital firm established in 1998 in Paris, France. The firm focuses on early-stage investments in sectors such as information technology, life sciences, and cybersecurity. With a portfolio of over 171 investments and 77 exits, Auriga Partners aims to support high-potential ventures and leverage its expertise and network for the growth of its portfolio companies. The firm has a strong interest in the Israeli market, with investments in Israeli startups like Gamida Cell.
Portfolio
No portfolio companies in this dataset yet.
Investment activity
1 portfolio exit on record.
Portfolio by sector
Health Tech & Life Sciences1
Q&A
- What is Auriga Partners' primary sector focus based on its investment activity?
- Auriga Partners has a concentrated focus on the Health Tech & Life Sciences sector, with all of its recorded portfolio companies and exits falling within this area.
- Can you name a notable exit for Auriga Partners?
- Auriga Partners had a notable exit in October 2018 with Gamida Cell, which went public on NASDAQ with a valuation of $210M.
- What is the total capital raised by Gamida Cell, a portfolio company of Auriga Partners?
- Gamida Cell, a portfolio company of Auriga Partners, raised a total of $416.22M before its IPO.
- What is Auriga Partners' investment stage preference?
- Auriga Partners has participated in various funding stages, including A Round, B Round, C Round, and E Round investments.
- When was Auriga Partners most active in making new portfolio investments?
- Auriga Partners made a new portfolio investment in May 2000.
- What is the typical investment range for Auriga Partners?
- Auriga Partners typically invests in the range of $6.37M to $10M.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1998 |
|---|